Claims for Patent: 10,206,894

✉ Email this page to a colleague

Summary for Patent: 10,206,894

Title:	Compounds for use in treatment of mucositis
Abstract:	The present invention provides methods for treating and/or preventing mucositis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
Inventor(s):	Scott; Richard W. (Radnor, PA), Korczak; Bozena (Wayne, PA)
Assignee:	Innovation Pharmaceuticals Inc. (Beverly, MA)
Application Number:	15/702,186
Patent Claims:	1. An oral, buccal, or sublingual pharmaceutical composition comprising a compound of the formula ##STR00549## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, wherein the compound is present at 1 mg/ml, 3 mg/ml, or 10 mg/ml. 2. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a liquid. 3. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a rinse. 4. The pharmaceutical composition of claim 1, wherein the compound is present at 1 mg/ml. 5. The pharmaceutical composition of claim 1, wherein the compound is present at 3 mg/ml. 6. The pharmaceutical composition of claim 1, wherein the compound is present at 10 mg/ml. 7. The pharmaceutical composition of claim 1, further comprising an analgesic. 8. The pharmaceutical composition of claim 1, further comprising an antibiotic. 9. The pharmaceutical composition of claim 1, further comprising palifermin. 10. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is an oral pharmaceutical composition. 11. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a buccal pharmaceutical composition. 12. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a sublingual pharmaceutical composition. 13. An oral, buccal, or sublingual pharmaceutical composition comprising a compound of the formula ##STR00550## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, and further comprising palifermin. 14. The pharmaceutical composition of claim 13, wherein the pharmaceutical composition is a liquid. 15. The pharmaceutical composition of claim 13, wherein the pharmaceutical composition is a rinse. 16. The pharmaceutical composition of claim 13, wherein the compound is present at 1 mg/ml. 17. The pharmaceutical composition of claim 13, wherein the compound is present at 3 mg/ml. 18. The pharmaceutical composition of claim 13, wherein the compound is present at 10 mg/ml.

Details for Patent 10,206,894

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Swedish Orphan Biovitrum Ab (publ)	KEPIVANCE	palifermin	For Injection	125103	December 15, 2004	⤷ Subscribe	2031-05-16
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.